Wilmington, DE, United States of America

Cyrus J Ohnmacht

USPTO Granted Patents = 28 

Average Co-Inventor Count = 3.3

ph-index = 6

Forward Citations = 73(Granted Patents)


Company Filing History:


Years Active: 1981-1999

Loading Chart...
28 patents (USPTO):Explore Patents

Title: **Cyrus J. Ohnmacht: An Innovator in Pharmaceutical Patents**

Introduction

Cyrus J. Ohnmacht, based in Wilmington, DE, is a prominent inventor with an impressive portfolio of 28 patents. His work focuses primarily on pharmaceutical innovations, specifically in the realm of compounds beneficial for treating various medical conditions such as asthma and urinary incontinence. His contributions to the field have significantly advanced the development of effective therapies.

Latest Patents

Among Cyrus J. Ohnmacht's latest innovations are patents for cyclic amide derivatives aimed at treating asthma. These compounds, defined by formula I, represent nonpeptide antagonists of neurokinin A, proving useful in the management of asthma symptoms. The patents also encompass the disclosures of pharmaceutical compositions, processes for preparing the compounds, and their intermediates. Furthermore, he has developed therapeutic compounds that target urinary incontinence, showcasing a deep understanding of the pharmaceutical industry and the needs of patients.

Career Highlights

Cyrus has made substantial contributions in the field while working with industry leaders such as Imperial Chemical Industries Limited and Zeneca Limited. These experiences have equipped him with the skills and knowledge necessary to navigate complex scientific challenges and drive innovation within the pharmaceutical sector.

Collaborations

Throughout his career, Cyrus J. Ohnmacht has collaborated with notable colleagues, including Diane A. Trainor and Keith Russell. These partnerships emphasize the collaborative nature of scientific research and innovation, leading to the successful development of groundbreaking therapeutic solutions.

Conclusion

Cyrus J. Ohnmacht has established himself as a key figure in pharmaceutical innovation through his numerous patents and collaborative efforts. His work continues to influence the industry, paving the way for advancements in treatment options for common yet impactful health issues such as asthma and urinary incontinence.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…